Medifast INC (MED) — 10-Q Filings

All 10-Q filings from Medifast INC. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Medifast Plunges to Q3 Loss Amid 36% Revenue Drop — Nov 3, 2025 Risk: high
Medifast, Inc. (MED) reported a significant decline in financial performance for the three and nine months ended September 30, 2025. Revenue decreased by 36.2%
Medifast Q2 Revenue Plunges 25% Amidst Stiff Competition — Aug 4, 2025 Risk: high
MEDIFAST INC reported a significant decline in financial performance for the second quarter ended June 30, 2025. Revenue decreased to $170.0 million, a substant
Medifast Files Q1 2025 10-Q Report — Apr 28, 2025 Risk: medium
Medifast Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 202
Medifast Inc. Files Q3 2024 10-Q Report — Nov 4, 2024 Risk: medium
Medifast Inc. reported its third-quarter results for the period ending September 30, 2024. The company's financial performance for this quarter and the year-to-
Medifast Inc. Files Q2 2024 10-Q Report — Aug 5, 2024 Risk: medium
Medifast Inc. reported its second quarter results for the period ending June 30, 2024. The company's financial performance for this quarter and the preceding si
Medifast Inc. Files 10-Q for Period Ending March 31, 2024 — Apr 29, 2024 Risk: low
MEDIFAST INC (MED) filed a Quarterly Report (10-Q) with the SEC on April 29, 2024. Medifast Inc. filed its quarterly report (10-Q) for the period ending March 3

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX